Dn B Asset Management As Biomarin Pharmaceutical Inc Call Options Transaction History
Dn B Asset Management As
- $19.9 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BMRN
# of Institutions
631Shares Held
185MCall Options Held
1.63MPut Options Held
1.2M-
Black Rock Inc. New York, NY22.7MShares$1.91 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.6 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.8MShares$1.58 Billion1.14% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$1.17 Billion0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$815 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $15.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...